Testing for Parkinson’s
FDA-approved technology differentiates between Parkinsonian syndromes and essential tremors
The Science Behind CereScan
Historically, movement disorders such as Parkinson’s disease have primarily been diagnosed through clinical examinations, which are often inconclusive and can result in misdiagnosis. Many patients who are currently being treated for Parkinson’s do not, in fact, have it. At CereScan, we use the DaTscanTM procedure to help distinguish between Parkinson’s and other movement disorders such as ataxia, dystonia, essential tremors, Lewy Body dementia, and drug-induced parkinsonism. The DaTscanTM shows how dopamine, a neurotransmitter, is distributed in your brain:
- Dopamine is an important brain chemical produced by neurons in areas of the brain which control movement
- When these neurons die or become impaired they produce less dopamine
- Visualizing a patient’s dopamine transporter status can help determine diagnosis
- Visualization of the dopamine transporter can add clarity to symptom presentation
- SPECT imaging with with DaTscan provides visual evidence of dopamine transporter status to aid in patient assessment and diagnosis
If you are on medications to treat PS and don’t actually have PS, the side effects may be significant and serious. If you think this might be the case, it’s time to get a clearer assessment. The results of the DaTscan will help your doctor in prescribing the proper treatment regimen. If you do not have PS, CereScan can conduct additional testing to determine what may be causing your symptoms.
We help remove the guesswork and bring clarity to your personal situation. An accurate diagnosis can allow you to better understand your condition and get off medications that may be causing negative side effects. You will be able to get proper treatment and receive the right medications to manage symptoms, if appropriate.